SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641489-24-000029
Filing Date
2024-05-09
Accepted
2024-05-09 16:32:45
Documents
64
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-20240331.htm   iXBRL 10-Q 747617
2 EX-31.1 vtvt-20240331xexx311.htm EX-31.1 10105
3 EX-31.2 vtvt-20240331xexx312.htm EX-31.2 10318
4 EX-32.1 vtvt-20240331xexx321.htm EX-32.1 4909
5 EX-32.2 vtvt-20240331xexx322.htm EX-32.2 4876
11 GRAHPIC vtvt-20240331_g1.jpg GRAPHIC 2361933
  Complete submission text file 0001641489-24-000029.txt   10465803

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20240331.xsd EX-101.SCH 41507
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtvt-20240331_cal.xml EX-101.CAL 46648
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20240331_def.xml EX-101.DEF 257429
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20240331_lab.xml EX-101.LAB 534833
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20240331_pre.xml EX-101.PRE 387788
68 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20240331_htm.xml XML 534113
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 24931295
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)